Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splice variant RAC1B in colorectal cells
A major risk factor promoting tumor development is chronic inflammation and the use of nonsteroidal anti-inflammatory drugs (NSAID), including ibuprofen, can decrease the risk of developing various types of cancer, including colorectal cancer (CRC). Although the molecular mechanism behind the antitu...
| Autor principal: | |
|---|---|
| Formato: | conferenceObject |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.18/7974 |
| País: | Portugal |
| Oai: | oai:repositorio.insa.pt:10400.18/7974 |